# Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance

> **NCT00856804** · PHASE2 · UNKNOWN · sponsor: **Valme University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00856804
- **Lead sponsor:** Valme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2009-06
- **Final completion:** 2012-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856804, "Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00856804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*